Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

NCT00278863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S-1
DRUG: Capecitabine

Sponsor

Asan Medical Center